Setareh Seyedkazemi is CHIEF DEVELOPMENT OFFICER at Adverum Biotechnologies, Inc. (ADVM). They have made 4 open-market trades across 1 company since 2022, most recently 2025-12-09.
CIK 0001903088
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $17K since 2022, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADVM | 88,332 | $385K |
Shares reported on the most recent Form 4, priced at the 2025-12-10 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.